Tinnitus: Difference between revisions
Line 143: | Line 143: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Recurrency | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Recurrency | ||
! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Nystagmus | ! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Nystagmus | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Hearing problems | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Hearing problems, tinnitus | ||
|- | |- | ||
| colspan="10" style="background: #7d7d7d; color: #FFFFFF; text-align: center;" |'''Peripheral''' | | colspan="10" style="background: #7d7d7d; color: #FFFFFF; text-align: center;" |'''Peripheral''' | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Ramsay Hunt syndrome type II|HSV oticus]]<br> | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Ramsay Hunt syndrome type II|HSV oticus]]<br> | ||
Line 185: | Line 154: | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +/− | | style="background: #F5F5F5; padding: 5px; text-align: center;" | +/− | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* loss of tastein the front two-thirds of the [[tongue]] | *loss of tastein the front two-thirds of the [[tongue]] | ||
* [[Acute facial nerve paralysis]] | *[[Acute facial nerve paralysis]] | ||
* [[Vesicles]] in the [[ear canal]], the [[tongue]], and/or [[hard palate]] | *[[Vesicles]] in the [[ear canal]], the [[tongue]], and/or [[hard palate]] | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | + [[Varicella zoster virus|VZV]] antibody titres | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + [[Varicella zoster virus|VZV]] antibody titres | ||
Line 193: | Line 162: | ||
*[[Magnetic resonance imaging|MRI]] with [[gadolinium]] contrast may show enhancement of the [[facial nerve]] and [[vestibulocochlear nerve]] | *[[Magnetic resonance imaging|MRI]] with [[gadolinium]] contrast may show enhancement of the [[facial nerve]] and [[vestibulocochlear nerve]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[History and Physical examination|History/ Physical exam]] | *[[History and Physical examination|History/ Physical exam]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* May be associated with [[otalgia]], [[dry mouth]] and [[dry eyes]] | *May be associated with [[otalgia]], [[dry mouth]] and [[dry eyes]] | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Ménière's disease|Meniere disease]]<br> | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Ménière's disease|Meniere disease]]<br> | ||
Line 204: | Line 173: | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | + (Progressive) | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + (Progressive) | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Sensorineural hearing loss]] | *[[Sensorineural hearing loss]] | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |− | | style="background: #F5F5F5; padding: 5px; text-align: center;" |− | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
*[[CT scan]] may show small or invisible [[vestibular aqueduct]] | *[[CT scan]] may show small or invisible [[vestibular aqueduct]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[History and Physical examination|History/ Physical exam]] | *[[History and Physical examination|History/ Physical exam]] | ||
*Ruling out other CNS and ear pathologies. | *Ruling out other CNS and ear pathologies. | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* May be associated with [[Nausea and vomiting|nausea]], [[Nausea and vomiting|vomiting]], and [[tinnitus]] | *May be associated with [[Nausea and vomiting|nausea]], [[Nausea and vomiting|vomiting]], and [[tinnitus]] | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Labyrinthine concussion<br> | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Labyrinthine concussion<br> | ||
Line 221: | Line 190: | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[high frequency hearing loss]] | *[[high frequency hearing loss]] | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |− | | style="background: #F5F5F5; padding: 5px; text-align: center;" |− | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
*[[CT scan]] may show evidence of [[head trauma]] or [[temporal bone]] [[fracture]] | *[[CT scan]] may show evidence of [[head trauma]] or [[temporal bone]] [[fracture]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[History and Physical examination|History/ Physical exam]] | *[[History and Physical examination|History/ Physical exam]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Follows blunt [[head trauma]] | *Follows blunt [[head trauma]] | ||
* May be associated with [[dizziness]] or [[tinnitus]] | *May be associated with [[dizziness]] or [[tinnitus]] | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Perilymphatic fistula]]<br> | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Perilymphatic fistula]]<br> | ||
Line 237: | Line 206: | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Tullio phenomenon]] | *[[Tullio phenomenon]] | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |− | | style="background: #F5F5F5; padding: 5px; text-align: center;" |− | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[CT scan]] may show fluid around the round window recess | *[[CT scan]] may show fluid around the round window recess | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[History and Physical examination|History/ Physical exam]]/[[Imaging]] | *[[History and Physical examination|History/ Physical exam]]/[[Imaging]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Complication of [[stapedectomy]], [[head injury]], or heavy lifting | *Complication of [[stapedectomy]], [[head injury]], or heavy lifting | ||
* It may be provoked by activities such as [[Sneeze|sneezing]], lifting, straining, [[Cough|coughing]], and loud sounds. (Tullio phenomenon) | *It may be provoked by activities such as [[Sneeze|sneezing]], lifting, straining, [[Cough|coughing]], and loud sounds. (Tullio phenomenon) | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Semicircular canal | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Semicircular canal | ||
Line 256: | Line 225: | ||
(air-bone gaps on audiometry) | (air-bone gaps on audiometry) | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Tullio phenomenon]] | *[[Tullio phenomenon]] | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |− | | style="background: #F5F5F5; padding: 5px; text-align: center;" |− | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[CT scan]] may show defect in the arcuate eminence of the [[superior semicircular canal]] | *[[CT scan]] may show defect in the arcuate eminence of the [[superior semicircular canal]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[History and Physical examination|History/ Physical exam]]/[[Imaging]] | *[[History and Physical examination|History/ Physical exam]]/[[Imaging]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* It may be provoked by [[Valsalva maneuver]], [[Cough|coughing]], and [[Sneeze|sneezing]] | *It may be provoked by [[Valsalva maneuver]], [[Cough|coughing]], and [[Sneeze|sneezing]] | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Cogan syndrome]]<br> | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |− | | style="background: #F5F5F5; padding: 5px; text-align: center;" |− | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +/− | | style="background: #F5F5F5; padding: 5px; text-align: center;" | +/− | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Interstitial keratitis]] | *[[Interstitial keratitis]] | ||
* [[Oscillopsia]] | *[[Oscillopsia]] | ||
* Absent [[vestibular function]] on [[Caloric reflex test|caloric test]] | *Absent [[vestibular function]] on [[Caloric reflex test|caloric test]] | ||
* [[Systemic vasculitis]] ([[Aortitis]]) | *[[Systemic vasculitis]] ([[Aortitis]]) | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Increased [[ESR]] and [[cryoglobulins]] | | style="background: #F5F5F5; padding: 5px; text-align: center;" |Increased [[ESR]] and [[cryoglobulins]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
*[[CT scan]] may show [[calcification]] or soft tissue attenuation obliterating the intralabyrinthine fluid spaces | *[[CT scan]] may show [[calcification]] or soft tissue attenuation obliterating the intralabyrinthine fluid spaces | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[History and Physical examination|History/ Physical exam]] | *[[History and Physical examination|History/ Physical exam]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* It may cause [[Ménière's disease|Ménière]]-like attacks | *It may cause [[Ménière's disease|Ménière]]-like attacks | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Vestibular schwannoma]]<br> | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Vestibular schwannoma]]<br> | ||
Line 308: | Line 258: | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Sensorineural hearing loss]] | *[[Sensorineural hearing loss]] | ||
* + [[Rinne test]] | *+ [[Rinne test]] | ||
* Lateralization of [[Weber test]] to the normal [[ear]] | *Lateralization of [[Weber test]] to the normal [[ear]] | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |− | | style="background: #F5F5F5; padding: 5px; text-align: center;" |− | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
*[[CT scan]] we may show erosion, and widening of the [[Internal auditory meatus|internal acoustic meatus]] | *[[CT scan]] we may show erosion, and widening of the [[Internal auditory meatus|internal acoustic meatus]] | ||
* T1-weighted [[MRI]] may show a hypointense mass lesion where as T-2 weighted MRI shows a hyperintense [[mass]] lesion | *T1-weighted [[MRI]] may show a hypointense mass lesion where as T-2 weighted MRI shows a hyperintense [[mass]] lesion | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Imaging]] | *[[Imaging]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Gadolinium]]-enhanced [[MRI]] scan is the definitive diagnostic test for [[Vestibular schwannoma|acoutic neuroma]] | *[[Gadolinium]]-enhanced [[MRI]] scan is the definitive diagnostic test for [[Vestibular schwannoma|acoutic neuroma]] | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Otitis media]]<br> | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Otitis media]]<br> | ||
Line 326: | Line 276: | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +/− | | style="background: #F5F5F5; padding: 5px; text-align: center;" | +/− | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Fever | *Fever | ||
* Presence of effusion in the [[middle ear]] | *Presence of effusion in the [[middle ear]] | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Increased [[Acute phase reactant|acute phase reactants]] | | style="background: #F5F5F5; padding: 5px; text-align: center;" |Increased [[Acute phase reactant|acute phase reactants]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Opacification of the [[middle ear]] | *Opacification of the [[middle ear]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[History and Physical examination|History/ Physical exam]] | *[[History and Physical examination|History/ Physical exam]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Patient may show other [[signs]] and [[symptoms]] of [[upper respiratory infection]] such as [[cough]], [[nasal discharge]], and [[fever]] | *Patient may show other [[signs]] and [[symptoms]] of [[upper respiratory infection]] such as [[cough]], [[nasal discharge]], and [[fever]] | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Aminoglycoside toxicity<br> | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Aminoglycoside toxicity<br> | ||
Line 342: | Line 292: | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Oscillopsia]] | *[[Oscillopsia]] | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |− | | style="background: #F5F5F5; padding: 5px; text-align: center;" |− | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |− | | style="background: #F5F5F5; padding: 5px; text-align: center;" |− | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[History and Physical examination|History/ Physical exam]] | *[[History and Physical examination|History/ Physical exam]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* | *May be associated with [[nausea]], [[vomiting]], and [[ataxia]] | ||
*possibly irreversible | |||
*[[Gentamicin]] is the most common one | |||
* | |||
|- style="background: #4479BA; color: #FFFFFF; text-align: center;" | |- style="background: #4479BA; color: #FFFFFF; text-align: center;" | ||
! colspan="10" style="background: #7d7d7d; color: #FFFFFF; text-align: center;" |Central | ! colspan="10" style="background: #7d7d7d; color: #FFFFFF; text-align: center;" |Central | ||
Line 377: | Line 310: | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +/− | | style="background: #F5F5F5; padding: 5px; text-align: center;" | +/− | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* History of [[migraine headaches]] | *History of [[migraine headaches]] | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |− | | style="background: #F5F5F5; padding: 5px; text-align: center;" |− | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
*[[MRI]] may show [[White matter|white-matter]] hyper-intensities (WMHs) | *[[MRI]] may show [[White matter|white-matter]] hyper-intensities (WMHs) | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* ICHD-3 criteria | *ICHD-3 criteria | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* It may be associated with [[anxiety]] and [[depression]] | *It may be associated with [[anxiety]] and [[depression]] | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Multiple sclerosis]]<br> | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |− | | style="background: #F5F5F5; padding: 5px; text-align: center;" |− | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +/− | | style="background: #F5F5F5; padding: 5px; text-align: center;" | +/− | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +/− | | style="background: #F5F5F5; padding: 5px; text-align: center;" | +/− | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Lhermitte's sign]] | *[[Lhermitte's sign]] | ||
* [[Spasticity]] | *[[Spasticity]] | ||
*[[Hyperreflexia]] | *[[Hyperreflexia]] | ||
* [[Internuclear ophthalmoplegia]] | *[[Internuclear ophthalmoplegia]] | ||
* [[Optic neuritis]] | *[[Optic neuritis]] | ||
* [[Gait disturbance]] | *[[Gait disturbance]] | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Elevated concentration of [[CSF]] [[oligoclonal bands]] | | style="background: #F5F5F5; padding: 5px; text-align: center;" |Elevated concentration of [[CSF]] [[oligoclonal bands]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
*[[CT scan]] shows brain atrophy and contrast enhanced demyelinating plaques | *[[CT scan]] shows brain atrophy and contrast enhanced demyelinating plaques | ||
*[[MRI scan|MRI]] showing cerebral plaques disseminating in time and space. | *[[MRI scan|MRI]] showing cerebral plaques disseminating in time and space. | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[History and Physical examination|History and physical examination]] | *[[History and Physical examination|History and physical examination]] | ||
* [[Imaging]] | *[[Imaging]] | ||
* [[CSF analysis]] | *[[CSF analysis]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[MS]] is twice as prevalent in women as compared to men | *[[MS]] is twice as prevalent in women as compared to men | ||
* The onset of [[symptoms]] is mostly between the age of fifteen to forty years and rarely before the age of fifteen or after the age of sixty years | *The onset of [[symptoms]] is mostly between the age of fifteen to forty years and rarely before the age of fifteen or after the age of sixty years | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Brain tumor|Brain tumors]]<br> | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Brain tumor|Brain tumors]]<br> | ||
Line 431: | Line 350: | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Papilledema]] | *[[Papilledema]] | ||
* [[Focal neurological deficits]] | *[[Focal neurological deficits]] | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Cerebral spinal fluid ([[CSF]]) may show cancerous cells | | style="background: #F5F5F5; padding: 5px; text-align: center;" |Cerebral spinal fluid ([[CSF]]) may show cancerous cells | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* On [[CT scan]] most of the [[brain tumors]] appears as a hypodense mass lesions | *On [[CT scan]] most of the [[brain tumors]] appears as a hypodense mass lesions | ||
* On T1- weighted [[MRI scan|MRI]] most of the [[brain tumors]] appears as a hypointense or Isointense whereas on T2-weighted [[MRI contrast agent|MRI]] they appear as hyperintense lesions | *On T1- weighted [[MRI scan|MRI]] most of the [[brain tumors]] appears as a hypointense or Isointense whereas on T2-weighted [[MRI contrast agent|MRI]] they appear as hyperintense lesions | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Imaging]] | *[[Imaging]] | ||
* [[Biopsy forceps|Biopsy]] | *[[Biopsy forceps|Biopsy]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* May experience [[headache]], [[seizures]], [[Visual disturbance|visual changes]] and changes in [[personality]], [[mood]] and [[concentration]] | *May experience [[headache]], [[seizures]], [[Visual disturbance|visual changes]] and changes in [[personality]], [[mood]] and [[concentration]] | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Cerebellar infarction]]/hemorrhage | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Cerebellar infarction]]/hemorrhage | ||
Line 448: | Line 367: | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |− | | style="background: #F5F5F5; padding: 5px; text-align: center;" |− | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | ++/− | | style="background: #F5F5F5; padding: 5px; text-align: center;" | ++/− | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |− | | style="background: #F5F5F5; padding: 5px; text-align: center;" | +/− | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Limb]] [[ataxia]] | *[[Limb]] [[ataxia]] | ||
* [[Gait abnormality|Gait disturbance]] | *[[Gait abnormality|Gait disturbance]] | ||
* [[Dysarthria]] | *[[Dysarthria]] | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |− | | style="background: #F5F5F5; padding: 5px; text-align: center;" |− | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Based on the time interval lapsed between the onset of [[stroke]] and [[imaging]] performed there may be different presentations | *Based on the time interval lapsed between the onset of [[stroke]] and [[imaging]] performed there may be different presentations | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Imaging]] | *[[Imaging]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Posterior inferior cerebellar artery]] is the most common artery that causes [[vertigo]] | *[[Posterior inferior cerebellar artery]] is the most common artery that causes [[vertigo]] | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Brain stem ischemia | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Brain stem ischemia | ||
Line 465: | Line 384: | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |− | | style="background: #F5F5F5; padding: 5px; text-align: center;" |− | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +/− | | style="background: #F5F5F5; padding: 5px; text-align: center;" | +/− | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +/− | |||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | + | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
*[[ | *Contralateral body [[Muscle weakness|weakness]] | ||
*[[Visual field]] deficits | |||
*[[Oculomotor nerve|Oculomotor]] abnormalities | |||
* [[ | *[[Bulbar]] findings | ||
* | |||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |− | | style="background: #F5F5F5; padding: 5px; text-align: center;" |− | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[ | *Based on the time interval lapsed between the onset of [[stroke]] and [[imaging]] performed there may be different presentations | ||
* | *For more information [[Ischemic stroke CT|click here]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[ | *[[Imaging]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* | *It may be associated with [[subclavian steal syndrome]] | ||
|} | |} | ||
'''ABBREVIATIONS''' | '''ABBREVIATIONS''' | ||
Line 533: | Line 412: | ||
==Risk Factors== | ==Risk Factors== | ||
* Age | *Age | ||
* Sensorineural hearing loss | *Sensorineural hearing loss | ||
* Loud noise exposure | *Loud noise exposure | ||
* Vestibular schwannoma | *Vestibular schwannoma | ||
* Ototoxic medication | *Ototoxic medication | ||
* History of anxiety and depression | *History of anxiety and depression | ||
* History of head trauma | *History of head trauma | ||
* History of multiple sclerosis | *History of multiple sclerosis | ||
==Natural History, Complications and Prognosis== | ==Natural History, Complications and Prognosis== | ||
Line 549: | Line 428: | ||
==Diagnosis== | ==Diagnosis== | ||
=== Diagnostic criteria: === | ===Diagnostic criteria:=== | ||
==== Tinnitus severity index (TSI) ==== | ====Tinnitus severity index (TSI)==== | ||
* TSI is used to rank the patient's based upon their severity | *TSI is used to rank the patient's based upon their severity | ||
* The score ranges from 0-45 | *The score ranges from 0-45 | ||
==== Tinnitus handicap questionnaire: ==== | ====Tinnitus handicap questionnaire:==== | ||
* This questionnaire includes 27 questions and is used to estimate the social, physical and emotional handicap severity | *This questionnaire includes 27 questions and is used to estimate the social, physical and emotional handicap severity | ||
==== Tinnitus handicap inventory: ==== | ====Tinnitus handicap inventory:==== | ||
* This questionnaire has 4 categories to classify severity | *This questionnaire has 4 categories to classify severity | ||
* None, mild, moderate, and severe. | *None, mild, moderate, and severe. | ||
===History and Symptoms:=== | ===History and Symptoms:=== |
Revision as of 02:11, 1 September 2020
WikiDoc Resources for Tinnitus |
Articles |
---|
Most recent articles on Tinnitus |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Tinnitus at Clinical Trials.gov Clinical Trials on Tinnitus at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Tinnitus
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Directions to Hospitals Treating Tinnitus Risk calculators and risk factors for Tinnitus
|
Healthcare Provider Resources |
Causes & Risk Factors for Tinnitus |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Kiran Singh, M.D. [2] Sabeeh Islam, MBBS[3]
Overview
Historical Perspective
- In the early 19th century, Frenchman and Jean Marie Gaspard Itard introduced the concept of masking. They were the first ones to differentiate between subjective and objective tinnitus.
- Later in the 19th Century, with the introduction of germ theory and anesthesia, surgical therapy such as incudectomy was established.
- Tinnitus is derived from the Latin word tinnire, meaning to ring.
Classification
Tinnitus can be classified as subjective and objective. This classification not only explains the underlying etiology but also directs the management of tinnitus.
Subjective tinnitus:
- It is only experienced by the affected individual in the absence of any auditory stimulation
- More common, usually described as continuous ringing, high pitch sound
Objective tinnitus:
- It is experienced not only by the affected individual but also by anyone else
- Relative rare, usually described as intermittent venous hum, low pitch sound
- It has an underlying vascular (abnormality of the carotid artery, jugular bulb or jugular vein) or muscular etiology (degenerative conditions such as amyotrophic lateral sclerosis) and usually caused by sound produced in ear, head or neck.
Pathophysiology
In the normal functioning auditory pathway, there is ordered tonotopic frequency mapping from the cochlea to the auditory cortex via midbrain. Conditions associated with cochlear damage result in altered tonotopic organization and ultimately tinnitus. The pathophysiology of tinnitus can be explained by the tinnitus model.
Lesion projection zone (LPZ):
This zone is defined as the area in the auditory cortex that represents the damaged cochlear input. The neurons in the LPZ zone show 2 main changes:
- Accelerated spontaneous firing rate
- Increased representation of neurons that represent the damaged cochlear region also known as lesion edge frequencies in the LPZ
Tinnitus model:
This model explains 2 major phenomena in the auditory cortex caused by lack of sensory peripheral auditory input (cochlea)
- Hyperactivity in the lesion projections zone (LPZ)
- Increased cortical representation of the lesion-edge frequencies in the LPZ
Causes of subjective tinnitus
Common Causes
Sensorineural hearing loss:
- Ototoxicity
- Presbycusis
- Noise induced hearing loss
- Late onset congenital hearing loss
- Idiopathic
Cochlear injury:
- Ménière disease
- Loop diuretics
- Platinum based chemotherapy
- Antibiotics
- Salicylate
- Trauma
Vascular causes:
- Systemic hypertension
- Sickle cell anemia
- Small vessel disease
- Hypercholesterolemia
- Hypercoagulable state
- Diabetic vasculopathy
CNS causes:
- Pseudotumor cerebri
- Stroke
- Vascular malformations
- Tumor
- Sarcoid
- Multiple sclerosis
Infections:
- Rubella
- Cytomegalovirus
- Chronic otitis media
- Neurosyphilis
- Measles
- Lyme disease
- Meningitis
Bone disease:
- Otosclerosis
- Fibrous dysplasia
- Osteogenesis imperfecta
- Paget disease
Metabolic disorders:
- Hyperparathyroidism
- Chronic renal failure
- Diabetes mellitus
- Thyroid disease
Autoimmune diseases:
- Autoimmune inner ear disease
- SLE
- Rheumatoid arthritis
Medications:
- ACE inhibitors
- Antimalarial medications
- Aminoglycosides
- Dapsone
- Doxazosin
- Calcium channel blockers
- Benzodiazepines
- Cisplatin
- Clarithromycin
- COX-2 inhibitors
- Loop diuretics
- Tricyclic antidepressant
Differential Diagnosis of Tinnitus
Diseases | Clinical manifestations | Para-clinical findings | Gold standard | Additional findings | |||||
---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical examination | ||||||||
Lab Findings | Imaging | ||||||||
Acute onset | Recurrency | Nystagmus | Hearing problems, tinnitus | ||||||
Peripheral | |||||||||
HSV oticus |
+ | +/− | − | +/− |
|
+ VZV antibody titres |
|
||
Meniere disease |
+/− | + | +/− | + (Progressive) | − |
|
|
||
Labyrinthine concussion |
+ | − | − | + | − |
|
| ||
Perilymphatic fistula |
+/− | + | − | + | − |
|
| ||
Semicircular canal
dehiscence syndrome |
+/− | + | − | +
(air-bone gaps on audiometry) |
− |
|
| ||
Cogan syndrome |
− | + | +/− | + | Increased ESR and cryoglobulins |
|
| ||
Vestibular schwannoma |
− | + | +/− | + |
|
− |
|
| |
Otitis media |
+ | − | − | +/− |
|
Increased acute phase reactants |
|
| |
Aminoglycoside toxicity |
+ | − | − | + | − | − |
| ||
Central | |||||||||
Vestibular migraine |
– | + | +/− | +/− |
|
− |
|
|
|
Multiple sclerosis |
− | + | +/− | +/− | Elevated concentration of CSF oligoclonal bands | ||||
Brain tumors |
+/− | + | + | + | Cerebral spinal fluid (CSF) may show cancerous cells |
|
| ||
Cerebellar infarction/hemorrhage | + | − | ++/− | +/− | − |
| |||
Brain stem ischemia | + | − | +/− | +/− |
|
− |
|
|
ABBREVIATIONS
VZV= Varicella zoster virus, MRI= Magnetic resonance imaging, ESR= Erythrocyte sedimentation rate, EEG= Electroencephalogram, CSF= Cerebrospinal fluid, GPe= Globus pallidus externa, ICHD= International Classification of Headache Disorders
Epidemiology and Demographics
- Tinnitus affects 10 to 15% of the population.
- 85% of the population presenting with ear symptoms/disorders report tinnitus as an associated symptom.
- The incidence rate of tinnitus increases with age and is more prevalent in older people.
Risk Factors
- Age
- Sensorineural hearing loss
- Loud noise exposure
- Vestibular schwannoma
- Ototoxic medication
- History of anxiety and depression
- History of head trauma
- History of multiple sclerosis
Natural History, Complications and Prognosis
- Early clinical features may include ear fullness, huming or ringing sensations in the ear
- If left untreated, patients may progress to functional impairment, insomnia, anxiety, and depression.
Diagnosis
Diagnostic criteria:
Tinnitus severity index (TSI)
- TSI is used to rank the patient's based upon their severity
- The score ranges from 0-45
Tinnitus handicap questionnaire:
- This questionnaire includes 27 questions and is used to estimate the social, physical and emotional handicap severity
Tinnitus handicap inventory:
- This questionnaire has 4 categories to classify severity
- None, mild, moderate, and severe.
History and Symptoms:
- Sounds such as ringing, buzzing, pulsatile, roaring and humming
- Progressive hearing loss
- Recent exposure to excessive or loud noise or head trauma
- Poor hygiene leading to cerumen impaction
- Ear pain
- History of certain medication exposure
Physical Examination:
- The ear examination may show signs of cerumen impaction, underlying infection or tympanic membrane perforation.
- Auscultation of neck, orbits and periauricular areas as helpful in establishing the diagnosis of vascular causes
- An extensive neurological examination may rule out underlying brainstem damage or hearing loss
- The Weber and Rinne test are done to establish sensorineural or conductive hearing loss
Laboratory Findings:
- There are no specific lab findings associated with tinnitis.
Imaging:
- MRA and CTA are the gold standard diagnostic tests for arteriovenous fistula related tinnitus.
- MRI with contrast is the initial preferred diagnostic test of choice for suspected vascular tinnitus.
- MRI with contrast is followed by CT/CTA and ultimately interventional angiography, if needed.
Other Diagnostic Testing:
- Initial audiometric tests are done to identify asymmetries between the ears and to locate the site of abnormality such as middle ear, cochlea, and brainstem. These tests include:
- Pure-tone audiogram
- Tympanometry
- Auditory reflex testing
- Determination of speech discrimination abilities
- Otoacoustic emissions testing
- Auditory brainstem response testing (ABR)
Treatment
- Tinnitus is a symptom and not a disease itself. It is a chronic condition that can be managed by treating the underlying etiology.
- The treatment of tinnitus is usually directed towards improvement in the quality of life by decreasing awareness or desensitizing towards tinnitus. It is usually achieved by identifying the underlying pathology or the associated disease.
- It is recommended to treat underlying insomnia and depression. (Grade 1B)
Medical Therapy
Following medications have minimal to modest role in relieving tinnitus.
- Misoprostol
- Lidocaine (intratympanic or intravenous)
- Benzodiazepine (alprazolam)
- Steroids such as dexamethasone (intratympanic)
- Carbamazepine
Following medications have been studied for tinnitus but are not found to be effective and have no role in the treatment of tinnitus
- Anticonvulsants
- Melatonin
- Ginkgo biloba
- Niacin
Surgery
- Cochlear implants may be considered for tinnitus associated with severe sensorineural hearing loss.
Other therapies:
- Tinnitus retraining therapy (TRT) (Grade 1C)
- Biofeedback (Grade 2C)
- Cognitive behavioral therapy (CBT) as an adjunct to TRT (Grade 2C)
- Acupuncture and electrical stimulation are considered equally effective as placebo, no significant role established so far.
Prevention
- Tinnitus may be been prevented by limiting the exposure to loud noise.